Prescription drug · NDA
Taclonex NDC 50222-501
calcipotriene and betamethasone dipropionate · Calcipotriene hydrate 50 ug/g; Betamethasone dipropionate .5 mg/g · Suspension · Topical · LEO Pharma Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50222-501-06 | 50222050106 | 40 CARTON in 1 CASE (50222-501-06) / 1 BOTTLE in 1 CARTON / 60 g in 1 BOTTLEMarketed from Jun 1, 2008 | |
| 50222-501-66 | 50222050166 | 10 PACKAGE in 1 BOX (50222-501-66) / 2 BOTTLE in 1 PACKAGE / 60 g in 1 BOTTLEMarketed from Jun 1, 2008 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Taclonex
- Generic name (nonproprietary)
- calcipotriene and betamethasone dipropionate
- Active ingredients
- Calcipotriene hydrate — 50 ug/gBetamethasone dipropionate — .5 mg/g
- Dosage form
- Suspension
- Route
- Topical
- Labeler
- LEO Pharma Inc.
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022185
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)Vitamin D (Chemical structure)
- Identifiers
- Product ID 50222-501_5d56e57e-6b91-4916-96d8-6dca1af7487dSPL ID 5d56e57e-6b91-4916-96d8-6dca1af7487dSPL set ID 757c914f-dd8d-43cc-a973-212d591af4afRxCUI 833461, 833463UNII S7499TYY6G, 826Y60901U
- Pharmacologic class
- Corticosteroid; Vitamin D Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450222050106followed by a unit qualifier and the quantityPackage 50222-0501-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Taclonex ® Topical Suspension is indicated for the topical treatment of plaque psoriasis of the scalp and body in patients 12 years and older. Taclonex Topical Suspension is a combination of calcipotriene, a vitamin D analog, and betamethasone dipropionate, a corticosteroid, indicated for the topical treatment of plaque psoriasis of the scalp and body in patients 12 years and older. ( 1 )
Excerpt only. Read the full label for complete information.